Loading...
M/s. Mylan Pharmaceuticals Inc, — Atovaquone Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #11 buyer for Atovaquone · $250.0K import value · 5 shipments · UNITED STATES · DGFT Verified
M/s. Mylan Pharmaceuticals Inc, is the #11 importer of Atovaquone from India with $250.0K in import value and 5 verified shipments. M/s. Mylan Pharmaceuticals Inc, holds a 0.0% market share in Atovaquone imports based in UNITED STATES. Overall, M/s. Mylan Pharmaceuticals Inc, imports 9 pharmaceutical products worth $8.0M across 7 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | $8.8M | 177 | 11 |
| HETERO LABS LIMITED | $6.8M | 137 | 4 |
| MYLAN LABORATORIES LIMITED | $2.9M | 58 | 5 |
| LUPIN LIMITED | $700.0K | 14 | 1 |
| GLENMARK PHARMACEUTICALS LTD | $400.0K | 8 | 3 |
| YASHICA PHARMACEUTICALS PRIVATE LIMITED | $189.7K | 5 | 4 |
| LIVEALTH BIOPHARMA PRIVATE LIMITED | $45.6K | 9 | 2 |
| KALINDI OVERSEAS | $38.6K | 10 | 3 |
| 3S PHARMACEUTICALS INDIA PRIVATE LIMITED | $26.9K | 5 | 2 |
| P.B.P ENTERPRISES PRIVATE LIMITED | $1.8K | 4 | 1 |
India's top Atovaquone suppliers include GLENMARK PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED. These companies represent the primary source of Atovaquone exports from India, serving buyers like M/s. Mylan Pharmaceuticals Inc, in UNITED STATES and other global markets.
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $300.0K | 6 | $50.0K |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $250.0K | 5 | $50.0K |
| 11 | M/S. MYLAN PHARMACEUTICALS INC, ★ | UNITED STATES | $250.0K | 5 | $50.0K |
| 14 | AMERISOURCE HEALTH SERVICES DBA AME | UNITED STATES | $250.0K |
What M/s. Mylan Pharmaceuticals Inc, and other importers must comply with to import Atovaquone from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $9.3M worth of Atovaquone through 437 shipments from 17 suppliers to 21 countries, serving 71 buyers globally. M/s. Mylan Pharmaceuticals Inc, imports $250.0K of this total, accounting for 0.0% of India's Atovaquone exports with 5 shipments from UNITED STATES.
M/s. Mylan Pharmaceuticals Inc,'s average Atovaquone order value is $50.0K per consignment, based on 5 shipments totaling $250.0K. M/s. Mylan Pharmaceuticals Inc, is based in UNITED STATES and ranks #11 among all Atovaquone importers from India by value.
Top Indian Atovaquone suppliers include GLENMARK PHARMACEUTICALS LIMITED ($8.8M), HETERO LABS LIMITED ($6.8M), MYLAN LABORATORIES LIMITED ($2.9M), LUPIN LIMITED ($700.0K), GLENMARK PHARMACEUTICALS LTD ($400.0K). These companies represent the primary source of Atovaquone exports from India.
M/s. Mylan Pharmaceuticals Inc, ranks #11 among 71 Atovaquone importers from India with a 0.0% market share. The top 3 importers are GLENMARK PHARMACEUTICALS INC., USA ($2.6M), GLENMARK PHARMACEUTICALS CANADA INC ($1.3M), MYLAN PHARMACEUTICALS INC ($1.3M). M/s. Mylan Pharmaceuticals Inc, processed 5 shipments from UNITED STATES.
M/s. Mylan Pharmaceuticals Inc, also imports these antimalarial & antiparasitic products. Each links to the detailed product page.
M/s. Mylan Pharmaceuticals Inc, imports 9 products worth $8.0M. Beyond Atovaquone, top products include Pantoprazole, Sodium, Valsartan, Hydrochlorothiazide, Acyclovir. View the complete M/s. Mylan Pharmaceuticals Inc, profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Atovaquone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for M/s. Mylan Pharmaceuticals Inc,'s Atovaquone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
M/s. Mylan Pharmaceuticals Inc,
Full Company Profile →
9 products · $8.0M total trade · 7 categories
| 5 |
| $50.0K |
| 13 | GLENMARK PHARMACEUTICALS INC. USA | UNITED STATES | $200.0K | 4 | $50.0K |
M/s. Mylan Pharmaceuticals Inc, ranks #11 among 71 Atovaquone importers from India. Average shipment value of $50.0K compared to the market average of $131.0K. The closest competitors by value are MYLAN PHARMACEUTICALS INC, and NORTHSTAR DISTRIBUTION CENTER 8912.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 21+ countries, 71+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for M/s. Mylan Pharmaceuticals Inc,.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atovaquone. For current order-level data, contact TransData Nexus.